Trivalent Sabin-strain IPV
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Trivalent Sabin-strain IPV, covering 2025-02-03 to 2025-02-03. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Assess the Safety, Reactogenicity and Immunogenicity of a Trivalent Inactivated Poliovirus Vaccine (IPV) Based on Sabin Strains Compared to Conventional Salk IPV in a 6, 10 and 14 Weeks of Age Immunization Schedule [Phase 2]